News

Halozyme has posted a net loss of $12.4m for the third quarter 2010, or $0.13 loss per diluted share, compared to net loss of $13.91m, or $0.16 loss

The study reported on the use of non-invasive technologies for quantitative sweat function, and correlated these results with the nature and location of ectodysplasin A (EDA) gene defects

The grants are being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care Act of 2010. NP001 is

According to Eisai, Crystal Veil can be used as a preventative measure against airborne allergens such as pollen and house dust by applying a single drop the size

Nutra Pharma is expected to use the grant proceeds to support additional clinical work on its pain treatments. Nutra Pharma chairman and CEO Rik Deitsch said that it

Aceto has posted a net income of $2.8m for the first quarter 2010, or $0.11 per diluted share, compared to $1m, or $0.04 per diluted share, for the

PV-10 is a proprietary, injectable formulation of Rose Bengal, a small molecule agent that has been in use for nearly 30 years by ophthalmologists to assess damage to

American Regent has initiated the voluntary recall because some vials of this lot were observed to be slightly discolored and upon standing have the appearance of sediment on

Celanese claims that VitalDose excipients are based on EVA polymers and offer a wide degree of flexibility in the design of transdermal, subcutaneous implant and mucosal insert dosage